Firtecan pegol Completed Phase 1 Trials for Neoplasm Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01251926 | EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors |